Quality Investor

DuPont de Nemours, Inc.

Rank #413Startup

DD · NYSE · Basic Materials

DuPont de Nemours, Inc. (DD) — Rank #413 by gross profitability (GP/assets 0.11) · ROE -5.7% · Piotroski F-Score N/A.

As-of 2026-09-28 · CIK 0001666700 · all metrics point-in-time as of the filing date.

About

DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa.

Show more

It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc.

was incorporated in 2015 and is headquartered in Wilmington, Delaware.

Industry
Specialty Chemicals
Sector
Basic Materials
State
DE
Filer Category
Large accelerated filer
Fiscal Year End
December 31
Website
dupont.com

Company Snapshot

P/S is the primary valuation lens for pre-profit companies.

Market Cap

—

P/E (annual)

—

P/S (annual)

—

P/B

—

P/OCF (annual)

—

Shareholder Yield

—

Employees

15,000

Industry

Specialty Chemicals

Exchange

NYSE

Signal Flags

2 green1 yellow
Revenue growth acceleratingGrowth rate increasing year over year
Sequential beat (rev + EPS)Both revenue and EPS exceeded prior quarter — 2-quarter streak
Disclosure regressionA previously-disclosed line item is no longer reported — worth checking the filing for why

Quality Profile

Profitability

1/1 pass
GP / assets
0.11
Return on equity
-5.7%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.52
Current ratio
2.43×
Net cash
$1.74B

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
0.6%

Growth

2/2 pass
Revenue growth
1.9%
Piotroski F-Score
N/A
Share dilution
0.0%

Terry Smith quality gate

Passes 0/5 Terry Smith thresholds

4 of 5 thresholds not computable from filed data.

Burn rate (cash flow) is the primary read at this stage — TAM and product-market fit aren't metrics this dashboard tracks.

Profitability

Gross profitability (GP / assets)

0.11

Primary signal (Novy-Marx).

21st pctl of 39 SIC 28 peers

Return on equity

-5.7%

Gross margin

34.5%

34th pctl of 39 SIC 28 peers

Revenue growth (YoY)

1.9%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2022202320242025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

-19.3%

Revenue CAGR (5Y)

-19.6%

Earnings CAGR (3Y)

—

FCF CAGR (3Y)

—

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.52

65th pctl of 35 SIC 28 peers (best = lowest)

Current ratio

2.43×

58th pctl of 39 SIC 28 peers

Quick ratio

1.32×

Net cash

$1.74B

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$227.00M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

1.29

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

0.6%

Stock-based comp intensity.

Dividend safety

Composite score

0.5 / 5

Weak
Payout ratio
N/A0/5 Weak
FCF coverage
0.38×0/5 Weak
Dividend growth streak
0 yr0/5 Weak
Balance-sheet health
D/E 0.52 · IC N/A2/5 Fair

Piotroski F-Score

F-Score

N/A

Only 8/9 components determinable.

Lifecycle Phase History

20202025
Decline
Value
Capital Return
Startup